글로벌 청각기기 시장 – 2023-2030

Global Audiology Devices Market - 2023-2030

상품코드DMMD1661
발행기관DataM Intelligence
발행일2023.01.05
페이지 수200 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

시장 개요
전 세계 청력 진단 기기 시장 규모는 2022년 YY백만 달러였으며, 2030년까지 YY백만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 5.8%입니다.
청력 진단 기기는 청력 전문가가 청력 손상을 진단하고 청각 장애가 있는 사람들을 돕기 위해 설계된 소리 증폭 장치입니다.
시장 동향
청력 손상 사례 증가와 고령 인구 증가는 예측 기간 동안 전 세계 청력 진단 기기 시장 성장을 촉진할 것으로 예상됩니다.
전 세계적으로 청력 손상 사례가 증가함에 따라 글로벌 시장 성장이 가속화되고 있습니다.
청력 손실이란 청력이 더 좋은 쪽 귀에서 35데시벨(dB) 이상의 청력 손실을 의미합니다. 전 세계적으로 청력 손상 사례가 증가함에 따라 글로벌 청력 진단 기기 시장 성장이 촉진되고 있습니다. 예를 들어, 세계보건기구(WHO)에 따르면 전 세계 인구의 5%에 해당하는 약 4억 3천만 명(성인 약 4억 3천2백만 명, 어린이 약 3천4백만 명)이 심각한 난청으로 인한 재활 치료가 필요합니다. WHO는 2050년에는 7억 명 이상이 심각한 난청을 겪을 것으로 추산하고 있습니다. 또한, 같은 기관은 부적절한 청취 습관으로 인해 약 10억 명의 젊은 성인이 영구적이고 예방 가능한 난청의 위협에 직면해 있다고 보고했습니다. 난청은 나이가 들수록 더욱 심해지는 경향이 있으며, 60세 이상 인구의 25% 이상이 심각한 난청을 겪고 있습니다.
마찬가지로, 미국 국립보건원(NIH)에 따르면 20~69세 성인의 난청 발생에 있어 나이는 가장 중요한 예측 변수이며, 특히 60~69세 연령대에서 난청 발생률이 가장 높습니다. 따라서 고령 인구의 증가는 예측 기간 동안 전 세계 청력 보조기기 시장의 성장을 견인할 것입니다. 예를 들어, 세계보건기구(WHO)에 따르면 2020년에는 60세 이상 인구가 5세 미만 아동 수를 넘어섰습니다. 전 세계 인구 6명 중 1명꼴로 60세 이상일 것으로 예상되며, 2030년에는 14억 명에 이를 것으로 전망됩니다. 2020년 60세 이상 인구는 10억 명이었고, 2050년에는 21억 명에 이를 것으로 예측됩니다. 80세 이상 인구는 4억 2,600만 명에 이를 것으로 예상됩니다. 따라서 위에서 언급한 데이터는 청각 장애 사례 증가와 고령 인구 증가가 예측 기간 동안 전 세계 시장 성장을 견인할 것임을 보여줍니다.
하지만 높은 청력 보조기기 가격은 시장 성장을 저해하는 요인으로 작용합니다.
보험 미적용 시 청각 뇌간 임플란트의 평균 비용은 약 3만 달러에서 5만 달러에 달하며, 이는 보험이 없는 대부분의 청각 장애인이 감당하기 어려운 수준입니다. 이러한 높은 비용은 전 세계 시장 성장을 제한하는 요인으로 작용합니다.

COVID-19 영향 분석
코로나19 팬데믹은 전 세계 청력 보조기기 시장에 상당한 영향을 미쳤습니다. 미국 국립보건원(NIH)에서 발표한 논문에 따르면, 2019년 코로나바이러스 감염증(COVID-19) 환자들이 급성 감각신경성 난청(SSNHL)을 겪을 위험이 있다는 증거가 점차 늘어나고 있습니다. COVID-19 관련 SSNHL의 병태생리는 아직 명확히 밝혀지지 않았지만, 이로 인해 청력 보조기기에 대한 수요가 증가했습니다. 또한, COVID-19 팬데믹으로 인해 의료진은 응급 상황에 우선적으로 대처해야 했습니다. 병원들이 응급 진료만 제공하면서 정기 검진 및 후속 치료를 받던 환자들이 차질을 빚었습니다. 그 결과, 많은 환자들이 난청 치료를 받지 못했지만, 이러한 상황은 점차 개선되고 있습니다. 따라서, 급성 감각신경성 난청(SSNHL)을 유발하는 COVID-19는 전 세계 시장에 긍정적인 영향을 미치고 있습니다.

부문 분석
소아 연령층은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
신제품 출시 및 시장 개발 증가로 인해 보청기 부문은 예측 기간 동안 높은 CAGR로 성장할 것으로 전망됩니다. 예를 들어, 2021년 12월 소노바(Sonova)는 청력 건강 회사인 누헤아라(Nuheara)와 계약을 체결했습니다. 이 계약을 통해 소노바와 전 세계 계열사는 누헤아라에서 제조 및 브랜드화한 제품을 공급받게 됩니다. 마찬가지로, 2021년 9월 소노바는 임상 단계 바이오테크 기업인 센소리온(Sensorion)과 협력했습니다. 이 협력은 성인 환자의 진행성 난청 진단에 유전자 분석을 통합하여 기존 보청기와 첨단 치료법을 결합함으로써 향상된 치료를 제공하는 것을 목표로 합니다. 또한, 2021년 8월 GN은 자사의 Jabra Enhance™ 청력 향상 솔루션 라인에 Jabra Enhance Plus를 출시했습니다. 새로운 제품은 경도에서 중등도 난청 환자들이 더욱 편리하게 들을 수 있도록 돕는 올인원 보청기입니다.
또한, 2020년 11월, 데만트는 오티콘, 베르나폰, 필립스 히어링 솔루션, 소닉에 보청기 기술을 적용했습니다. 더불어, 2020년 8월 GN 히어링은 새로운 보청기인 리사운드 원(ReSound ONE)을 출시했습니다. 이 새로운 솔루션은 외이도에 추가 마이크를 장착하여 난청 환자들이 적절한 청력을 경험할 수 있도록 함으로써 난청으로 인한 어려움을 해결하는 것을 목표로 합니다. 또한, 2021년 3월 코클리어는 코클리어 바하 6 맥스 사운드 프로세서(Cochlear Baha 6 Max Sound Processor)에 대해 미국 FDA 승인을 획득했습니다. 이 제품은 편측성 난청 및 혼합성 또는 전도성 난청 환자의 청력 개선을 위해 개발되었습니다. 2021년, 보청기 혁신의 글로벌 리더인 GN Hearing은 최첨단 칩 플랫폼과 GN의 '유기적 청력(Organic Hearing)' 철학을 접목한 ReSound Key™ 보청기 포트폴리오를 출시하여 사회적 고립 속에서도 청각 장애인들이 다른 사람들과 소통할 수 있도록 지원했습니다. 따라서 위의 데이터는 보청기 부문이 전 세계 청각 기기 시장에서 상당한 점유율을 차지하고 있음을 보여줍니다.
지역 분석
북미 지역은 청각 기기 시장에서 가장 큰 점유율을 차지하고 있습니다.
미국 난청 협회(Hearing Loss Association of America)에 따르면 난청은 미국 노년층에서 세 번째로 흔한 질환으로, 약 4,800만 명(미국 인구의 20%)에게 영향을 미치며, 이 중 2,880만 명의 미국 성인이 보청기 사용으로 혜택을 볼 수 있을 것으로 예상됩니다. 또한, 정부 및 비정부 기관들이 청각 장애인의 삶의 질 향상을 위해 적극적으로 노력하고 있습니다. 예를 들어, 미국 청각장애인협회(National Association of Deaf), 미국 난청협회(Hearing Loss Association of America), 재활청각학회(Academy of Rehabilitative Audiology, ARA), 청각학 박사 협회(Academy of Doctors of Audiology, ADA), 청각장애인 및 난청인을 위한 알렉산더 그레이엄 벨 협회(Alexander Graham Bell Association), 미국청각학회(American Academy of Audiology, AAA) 등이 있습니다. 더욱이, 이 지역의 시장 발전은 북미가 세계 청각학 시장을 주도하는 데 기여하고 있습니다. 예를 들어, 2022년 3월, 스타키(Starkey)는 스페셜 올림픽과 협력하여 지적 장애인을 위한 청력 건강 서비스 접근성을 전 세계적으로 확대했습니다.
마찬가지로, 2020년 10월에는 스타키(미국)가 오르캠 테크놀로지스(OrCam Technologies, 이스라엘)와 협력하여 청각 및 외적 장애가 있는 사람들을 위한 보조 장치를 개발했습니다. 또한, 2022년 2월에는 미국에 본사를 둔 청각 기술 제품 및 솔루션 회사인 오티콘(Oticon Inc.)이 BTE 및 ITE 부문에 오티콘 플레이 P.X.(Oticon Play P.X.)와 오티콘 지르콘(Oticon zircon)이라는 두 가지 새로운 모델을 출시했습니다. 또한, 2022년 10월 미국 FDA는 소비자들이 매장이나 온라인 소매점에서 보청기를 즉시 구매할 수 있도록 허용했습니다. 이제 소비자들은 의사의 처방전, 건강 검진, 청력 전문가의 조정 없이도 일반의약품(OTC) 보청기를 즉시 구매할 수 있습니다. 더불어, 2022년 3월 소노바(Sonova)는 미국의 독립 청력 관리 클리닉 네트워크인 알파카 청력학(Alpaca Audiology)을 인수했습니다. 따라서 위에서 언급한 자료들은 북미 지역이 예측 기간 동안 전 세계 청력 기기 시장을 주도할 것임을 시사합니다.

경쟁 환경
청력 기기 분야의 지속적인 혁신은 시장 참여자들 간의 적절한 경쟁을 유지하고 있습니다. 주요 시장 참여자로는 코클리어(Cochlear Limited), 메드엘(Med-EL), 오티콘 메디컬(Oticon Medical), 뉴로트론 바이오테크놀로지(Nurotron’s Biotechnology Co. Ltd.), 소노바 홀딩(Sonova Holding AG), 스타키 히어링 테크놀로지스(Starkey Hearing Technologies), 지멘스(Siemens AG), 포낙(Phonak), GN 히어링(덴마크), 어드밴스드 바이오닉스(Advanced Bionics) 등이 있습니다. 이러한 주요 업체들은 혁신, 신제품 출시, 협력, 인수 및 제휴를 통해 시장 점유율의 대부분을 차지하고 있습니다. 예를 들어, 2021년 2월 코클리어(Cochlear)는 청각 건강 분야의 선도적인 전문가들과 협력하여 글루코코르티코이드(항염증제) 약물을 와우에 직접 방출하는 연구용 인공와우에 대한 사상 최대 규모의 다기관 무작위 대조 시험(RCT)을 진행했습니다. 또한, 2021년 9월 말랄라 재단(Malala Fund)과 코클리어 재단(Cochlear Foundation)은 코클리어의 지원을 받아 난청 아동 및 청소년이 잠재력을 최대한 발휘할 수 있도록 돕는 파트너십을 체결했습니다.

오티콘 메디컬(Oticon Medical)
개요:
오티콘 메디컬은 청각 솔루션 산업의 글로벌 리더이며, 1904년에 설립되어 덴마크 코펜하겐에 본사를 두고 있습니다.

제품 포트폴리오:
오티콘 메디컬(Oticon Medical)의 청각 기기 제품 포트폴리오에는 뉴로 Zti 인공와우가 포함됩니다. 뉴로 Zti 임플란트 수신기는 생체 적합성 덕분에 의료 분야에서 널리 사용되는 지르코니아와 티타늄으로 제작됩니다. 또한 이러한 혁신적인 소재 덕분에 작고 견고하며 일상생활에서 발생하는 충격을 흡수할 수 있는 임플란트 디자인이 가능합니다.
글로벌 청각 기기 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량으로 구성되어 있습니다.

보고서 요약(영어 원문)

Market Overview
The global audiology devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.8% during the forecast period (2023-2030).
Audiology devices are sound-amplifying devices designed to aid audiologists in diagnosing hearing impairment in people and help them with hearing disabilities.
Market Dynamics
The growing hearing impairment cases and geriatric population is promoting the global audiology device market during the forecast period.
The growing cases of hearing impairment worldwide are accelerating global market growth.
Disabling hearing loss refers to hearing loss greater than 35 decibels (dB) in the better-hearing ear. The growing cases of hearing impairment worldwide boost the global audiology device market growth. For instance, according to the WHO, more than 430 million people comprising about 432 million adults and around 34 million children, accounting for 5% of the world’s population, need rehabilitation to manage their ‘disabling’ hearing loss. According to WHO estimation, more than 700 million people will have disabling hearing loss in 2050. Also, the same source has reported that permanent, avoidable hearing disabilities threaten around 1 billion young adults because of unsafe listening practices. The preponderance of hearing loss improves with age. Over 25% of older than 60 years population is affected by disabling hearing loss.
Similarly, according to the National Institutes of Health, age is the most assertive predictor of hearing loss in adults aged 20-69, with the most significant portion of hearing loss in the 60 to 69 age group. Therefore, the growing geriatric population ensures the global audiology device market growth throughout the forecast period. For instance, according to the WHO, the number of people aged 60 and older outnumbered children younger than five in 2020. About 1 out of 6 people worldwide will be 60 years or over, accounting for 1.4 billion in 2030. In 2020 the share of the population aged 60 years and over was 1 billion, and the world’s population of people aged 60 years and older will be 2.1 billion by 2050. The population of persons aged 80 years or older is anticipated to reach 426 million. Thus, the data mentioned above indicates that the growing cases of hearing impairment and the geriatric population fuel the global market growth throughout the forecast period.
The high cost of audiology devices is hampering the market growth.
The average cost of an auditory brain stem implant without insurance is around $30000 to $50000, which leaves most of the disabled hearing population without insurance unable to afford thereby restraining the global market growth.
COVID-19 Impact Analysis
The pandemic has significantly impacted the global audiology device market. According to an article published by NIH, a growing body of evidence suggests that patients with the 2019 Coronavirus disease (COVID-19) risk developing sudden sensorineural hearing loss (SSNHL). The pathogenesis of COVID-19-related SSNHL remains unclear, which has led to increased demand for audiological devices. Furthermore, the COVID-19 global pandemic has forced healthcare specialists to address emergencies as a priority. Patients with routine consultation and follow-up care were interrupted due to hospitals delivering only emergency services. Therefore, many patients were neglected from hearing disorders treatment, but the situation is getting resolved. Therefore, COVID-19, causing sudden sensorineural hearing loss (SSNHL), positively impacts the global market.
Segment Analysis
The pediatric age group is expected to grow at the fastest CAGR during the forecast period (2022-2029)
Owing to increased product launches and market developments, the hearing aids segment is forecasted to grow at a high CAGR throughout the projection period. For instance, in Dec 2021, Sonova formed an agreement with Nuheara, a hearing health company. Through this, Sonova and its affiliates worldwide will have the supply of Nuheara company-manufactured and branded products. Similarly, in Sep 2021, Sonova collaborated with Sensorion, a clinical-stage biotech company. The collaboration is planned to incorporate genetic analysis into the routine diagnosis of developed hearing loss in adult patients to deliver improved care via integrating conventional hearing aids with advanced therapeutic interventions. Likewise, in Aug 2021, GN launched Jabra Enhance Plus in its Jabra EnhanceTM line of hearing enhancement solutions. The new product is an all-in-one audible for patients who encounter mild-to-moderate hearing loss to aid them in hearing more conveniently.
Additionally, in Nov 2020, Demant rolled out hearing aid technology in its Oticon, Bernafon, Philips Hearing Solutions, and Sonic. Moreover, Aug 2020, GN Hearing introduced ReSound ONE, a new hearing aid. The new solution aimed to address complications for people with hearing loss by putting an additional microphone within the ear canal and allowing them to experience adequate hearing capacities. Also, in March 2021, Cochlear Ltd. acquired U.S. FDA clearance for the Cochlear Baha 6 Max Sound Processor. It is planned to improve hearing quality for unilateral deafness and mixed or conductive hearing loss. In 2021, GN Hearing, the global leader in hearing aid innovation, introduced ReSound Key™ hearing aid portfolio with a state-of-the-art chip platform and GN’s Organic Hearing philosophy helping patients to connect with others during social isolation. Thus the data mentioned above indicates that the hearing aids segment holds the majority of the global audiology device market share.
Geographical Analysis
The North American region hosts the largest audiology devices market share.
The Hearing Loss Association of America states that hearing loss is the third most dominant condition in older U.S. adults, impacting about 48 million, accounting for 20% of the American population, and 28.8 million U.S. adults could profit from using hearing aids. Furthermore, the existence of Govt. and non-Govt. Organizations operate to outstretch attention and help out deaf people to attain the best quality of life. Examples are the National Association of Deaf, the Hearing Loss Association of America, the Academy of Rehabilitative Audiology (ARA), the Academy of Doctors of Audiology (ADA), the Alexander Graham Bell Association working for Deaf and Hard of Hearing, the American Academy of Audiology (AAA), and multiple more. Moreover, the market developments in this region ensure North America's dominance over the global audiology market. For instance, in March 2022, Starkey and Special Olympics partnered to increase access to hearing health services worldwide for people with intellectual disabilities.
Similarly, in October 2020, Starkey (U.S.) collaborated with OrCam Technologies (Israel) to deliver assistive advancements to hearing and outwardly impeded individuals. Likewise, in February 2022, Oticon Inc., a U.S.-based audiology technology products and solutions company launched two new models Oticon Play P.X. and Oticon zircon, into its BTE and ITE segments. Additionally, in October 2022, the U.S. FDA granted the option to purchase hearing aids instantly from stores or online retailers. Customers can instantly buy Over-The-Counter (OTC) hearing aids without requiring a doctor's prescription, medical test or fitting adjustment by an audiologist. Moreover, in March 2022, Sonova took over Alpaca Audiology, an independent audiological care clinic network in the U.S. Therefore, the data mentioned above indicate that North America will dominate the global audiology device market in the forecasted period.
Competitive Landscape
The expanding innovations in audiology devices keep moderate competition among the market players. Some key market players are Cochlear Limited, Med-EL, Oticon Medical, Nurotron’s Biotechnology Co. Ltd., Sonova Holding AG, Starkey Hearing Technologies, Siemens AG, Phonak, GN Hearing (Denmark) and Advanced Bionics. These key players hold most of the market share through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in February 2021, Cochlear partnered with leading hearing health experts to conduct the largest ever multi-center, randomized controlled trial (RCT) of an investigational cochlear implant that releases a glucocorticoid (anti-inflammatory) drug therapy directly to the cochlea. Also, in September 2021, Malala Fund and Cochlear Foundation formed a partnership, supported by Cochlear, to help children and young people with hearing loss realize their full potential.
Oticon Medical
Overview:
Oticon Medical is a global leader in the hearing solutions industry; it was founded in 1904 and is based in Copenhagen, Denmark.
Product Portfolio:
Oticon Medical’s product portfolio for audiology devices has Neuro Zti cochlear implants: Because of their biocompatibility, the Neuro Zti implant receiver is constructed of zirconia and titanium, widely used materials in the medical field. In addition, these innovative materials allow an implant design that is small, highly robust and able to sponge impacts experienced in daily life.
The global audiology devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Geriatric Population
4.1.1.2. Increasing Burden of Hearing Loss
4.1.2. Restraints
4.1.2.1. High Cost
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Digital
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Analog
8. By Product Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Hearing Aids
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Cochlear Implants
8.4. BAHA/BAHS
8.5. Diagnostic Devices
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Retail Sales
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Online Stores
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Company Profiles
12.1. Oticon Medical
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Cochlear Limited
12.3. Med-EL
12.4. Nurotron’s Biotechnology Co. Ltd.
12.5. Sonova Holding AG
12.6. Starkey Hearing Technologies
12.7. Siemens AG
12.8. Phonak
12.9. GN Hearing (Denmark)
12.10. Advanced Bionics
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

Oticon Medical, Cochlear Limited, Med-EL, Nurotron’s Biotechnology Co. Ltd., Sonova Holding AG, Starkey Hearing Technologies, Siemens AG, Phonak, GN Hearing (Denmark), Advanced Bionics

표 목록 (Tables)

List of Tables

Table 1 Global Audiology Devices Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Audiology Devices Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Audiology Devices Market Value, By Indication, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Audiology Devices Market Value, By Distribution Channel, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Audiology Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Audiology Devices Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Audiology Devices Market Value, By Technology, 2021-2030 (US$ Million)

Table 8 Global Audiology Devices Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Audiology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 10 Global Audiology Devices Market Value, By Indication, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Audiology Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 12 Global Audiology Devices Market Value, By Distribution Channel, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Audiology Devices Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 14 Global Audiology Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Audiology Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Audiology Devices Market Value, By Technology, 2021-2030 (US$ Million)

Table 17 North America Audiology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 18 North America Audiology Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 19 North America Audiology Devices Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 20 North America Audiology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Audiology Devices Market Value, By Technology, 2021-2030 (US$ Million)

Table 22 South America Audiology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 23 South America Audiology Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 24 South America Audiology Devices Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 25 South America Audiology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Audiology Devices Market Value, By Technology, 2021-2030 (US$ Million)

Table 27 Europe Audiology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 28 Europe Audiology Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 29 Europe Audiology Devices Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 30 Europe Audiology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Audiology Devices Market Value, By Technology, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Audiology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Audiology Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Audiology Devices Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Audiology Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Audiology Devices Market Value, By Technology, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Audiology Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Audiology Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Audiology Devices Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 40 Oticon Medical: Overview

Table 41 Oticon Medical: Product Portfolio

Table 42 Oticon Medical: Key Developments

Table 43 Med-EL: Overview

Table 44 Med-EL: Product Portfolio

Table 45 Med-EL: Key Developments

Table 46 Starkey Hearing Technologies: Overview

Table 47 Starkey Hearing Technologies: Product Portfolio

Table 48 Starkey Hearing Technologies: Key Developments

Table 49 Phonak: Overview

Table 50 Phonak: Product Portfolio

Table 51 Phonak: Key Developments

Table 52 Advanced Bionics: Overview

Table 53 Advanced Bionics: Product Portfolio

Table 54 Advanced Bionics: Key Developments

Table 55 Audina Hearing Instruments, Inc.: Overview

Table 56 Audina Hearing Instruments, Inc.: Product Portfolio

Table 57 Audina Hearing Instruments, Inc.: Key Developments

Table 58 Coselgi: Overview

Table 59 Coselgi: Product Portfolio

Table 60 Coselgi: Key Developments

Table 61 Sonova AG: Overview

Table 62 Sonova AG: Product Portfolio

Table 63 Sonova AG: Key Developments

Table 64 WS Audiology A/S: Overview

Table 65 WS Audiology A/S: Product Portfolio

Table 66 WS Audiology A/S: Key Developments

Table 67 BHM-Tech Produktionsgesellschaft mbH: Overview

Table 68 BHM-Tech Produktionsgesellschaft mbH: Product Portfolio

Table 69 BHM-Tech Produktionsgesellschaft mbH: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Audiology Devices Market Share, By Technology, 2022 & 2030 (%)

Figure 3 Global Audiology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 4 Global Audiology Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 5 Global Audiology Devices Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 6 Global Audiology Devices Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Audiology Devices Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 8 Digital Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Analog Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Global Audiology Devices Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 11 Hearing Aids Product Type in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Cochlear Implants Product Type in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 13 Bone Conduction Devices Product Type in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Diagnostic Devices Product Type in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Global Audiology Devices Market Y-o-Y Growth, By Indication, 2022-2030 (%)

Figure 16 Otosclerosis Indication in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Meniere’s Disease Indication in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Acoustic Tumors Indication in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Otitis Media Indication in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Others Indication in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Global Audiology Devices Market Y-o-Y Growth, By Distribution Channel, 2022-2030 (%)

Figure 22 Retail Sales Distribution Channel in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 23 Online Stores Distribution Channel in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 24 Government Purchases Distribution Channel in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 25 E-Commerce Distribution Channel in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 26 Others Distribution Channel in Global Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 27 Global Audiology Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 28 North America Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 29 Asia-Pacific Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 30 Europe Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 31 South America Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 32 Middle East and Africa Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 33 North America Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 34 North America Audiology Devices Market Share, By Technology, 2022 & 2030 (%)

Figure 35 North America Audiology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 36 North America Audiology Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 37 North America Audiology Devices Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 38 North America Audiology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 39 South America Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 40 South America Audiology Devices Market Share, By Technology, 2022 & 2030 (%)

Figure 41 South America Audiology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 42 South America Audiology Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 43 South America Audiology Devices Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 44 South America Audiology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 45 Europe Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 46 Europe Audiology Devices Market Share, By Technology, 2022 & 2030 (%)

Figure 47 Europe Audiology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 48 Europe Audiology Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 49 Europe Audiology Devices Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 50 Europe Audiology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 51 Asia-Pacific Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 52 Asia-Pacific Audiology Devices Market Share, By Technology, 2022 & 2030 (%)

Figure 53 Asia-Pacific Audiology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 54 Asia-Pacific Audiology Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 55 Asia-Pacific Audiology Devices Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 56 Asia-Pacific Audiology Devices Market Share, By Country, 2022 & 2030 (%)

Figure 57 Middle East & Africa Audiology Devices Market Value, 2021-2030 (US$ Million)

Figure 58 Middle East & Africa Audiology Devices Market Share, By Technology, 2022 & 2030 (%)

Figure 59 Middle East & Africa Audiology Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 60 Middle East & Africa Audiology Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 61 Middle East & Africa Audiology Devices Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 62 Oticon Medical: Financials

Figure 63 Med-EL: Financials

Figure 64 Starkey Hearing Technologies: Financials

Figure 65 Phonak: Financials

Figure 66 Advanced Bionics: Financials

Figure 67 Audina Hearing Instruments, Inc.: Financials

Figure 68 Coselgi: Financials

Figure 69 Sonova AG: Financials

Figure 70 WS Audiology A/S: Financials

Figure 71 BHM-Tech Produktionsgesellschaft mbH: Financials